DBV Technologies | DBVT - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Acadia Pharmaceuticals USD 8.33M 86K 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Amarin USD 3.37M 3.37M 2024-12
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
DBV Technologies USD -0.32 0.02 2024-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Galectin Therapeutics USD -2.71M 2.77M 2023-12
Incyte USD 33.69M 2.93M 2026-03
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Sarepta Therapeutics USD 8.74M 359K 2025-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
United Therapeutics USD 43.2M 3.2M 2025-12